Impediment of NEMO oligomerization inhibits osteoclastogenesis and osteolysis

The transcription factor NF‐κB is essential for osteoclastogenesis and is considered an immune‐modulator of rheumatoid arthritis and inflammatory osteolysis. Activation of NF‐κB subunits is regulated by the upstream IκB kinase (IKK) complex which contains IKKα, IKKβ, and IKKγ; the latter also known as NF‐κB essential modulator (NEMO). The role of IKKα and IKKβ in the skeletal development and inflammatory osteolysis has been described, whereas little is known regarding the role of NEMO in this setting. Typically, signals induced by RANK ligand (RANKL) or TNF prompt oligomerization of NEMO monomers through the coiled‐coil‐2 (CC2) and leucine zipper (LZ) motifs. This step facilitates binding to IKKs and further relaying signal transduction. Given the central role of NF‐κB in osteoclastogenesis, we asked whether NEMO is essential for osteoclastogenesis and whether interruption of NEMO oligomerization impedes osteoclast differentiation in vitro and in vivo. Using cell‐permeable short peptides overlapping the CC2 and LZ motifs we show that these peptides specifically bind to NEMO monomers, prevent trimer formation, and render NEMO monomers susceptible for ubiquitin‐mediated degradation. Further, CC2 and LZ peptides attenuate RANKL‐ and TNF‐induced NF‐κB signaling in bone marrow‐derived osteoclast precursors (OCPs). More importantly, these peptides potently inhibit osteoclastogenesis, in vitro, and arrest RANKL‐induced osteolysis, in mice. To further ascertain its role in osteoclastogenesis, we were able to block osteoclastogenesis using NEMO siRNA knockdown approach. Collectively, our data establish that obstruction of NEMO oligomerization destabilizes NEMO monomers, inhibits NF‐κB activation, impedes osteoclastogenesis and arrests inflammatory osteolysis. Thus, NEMO presents itself as a promising target for anti‐osteolytic intervention. J. Cell. Biochem. 108: 1337–1345, 2009. © 2009 Wiley‐Liss, Inc.

[1]  S. Akira,et al.  Involvement of linear polyubiquitylation of NEMO in NF-κB activation , 2009, Nature Cell Biology.

[2]  J. Vacher,et al.  Defective Osteoclastogenesis by IKKβ-null Precursors Is a Result of Receptor Activator of NF-κB Ligand (RANKL)-induced JNK-dependent Apoptosis and Impaired Differentiation* , 2008, Journal of Biological Chemistry.

[3]  R. Faccio,et al.  RelA/p65 promotes osteoclast differentiation by blocking a RANKL-induced apoptotic JNK pathway in mice. , 2008, The Journal of clinical investigation.

[4]  Vrajesh V. Parekh,et al.  Cutting Edge: K63-Linked Polyubiquitination of NEMO Modulates TLR Signaling and Inflammation In Vivo1 , 2008, The Journal of Immunology.

[5]  W. Zou,et al.  RelB is the NF-κB subunit downstream of NIK responsible for osteoclast differentiation , 2008, Proceedings of the National Academy of Sciences.

[6]  M. Karin The IκB kinase – a bridge between inflammation and cancer , 2008, Cell Research.

[7]  David L. Smith,et al.  Signal processing by its coil zipper domain activates IKKγ , 2008, Proceedings of the National Academy of Sciences.

[8]  M. Omata,et al.  Cutting Edge: The IκB Kinase (IKK) Inhibitor, NEMO-Binding Domain Peptide, Blocks Inflammatory Injury in Murine Colitis1 , 2007, The Journal of Immunology.

[9]  Y. Abu-Amer,et al.  Inhibition of inflammatory bone erosion by constitutively active STAT-6 through blockade of JNK and NF-kappaB activation. , 2005, Arthritis and rheumatism.

[10]  Inder M. Verma,et al.  Enhanced NF-κB activation and cellular function in macrophages lacking IκB kinase 1 (IKK1) , 2005 .

[11]  Georg Schett,et al.  IκB kinase (IKK)β, but not IKKα, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss , 2005, The Journal of experimental medicine.

[12]  C. Bodemer,et al.  NEMO Mutations in 2 Unrelated Boys With Severe Infections and Conical Teeth , 2005, Pediatrics.

[13]  Toby Lawrence,et al.  IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation , 2005, Nature.

[14]  F. Martinon,et al.  Inflammatory Diseases: Is Ubiquitinated NEMO at the Hub? , 2004, Current Biology.

[15]  S. Akira,et al.  Osteoclast Differentiation Is Impaired in the Absence of Inhibitor of κB Kinase α* , 2004, Journal of Biological Chemistry.

[16]  G. Courtois,et al.  Inhibition of NF-κB Activation by Peptides Targeting NF-κB Essential Modulator (NEMO) Oligomerization* , 2004, Journal of Biological Chemistry.

[17]  Y. Abu-Amer,et al.  The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis. , 2004, The Journal of biological chemistry.

[18]  G. Courtois,et al.  The Trimerization Domain of Nemo Is Composed of the Interacting C-terminal CC2 and LZ Coiled-coil Subdomains* , 2004, Journal of Biological Chemistry.

[19]  Koji Okabe,et al.  Selective inhibition of NF-κB blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo , 2004, Nature Medicine.

[20]  J. Clohisy,et al.  Direct Inhibition of NF-κB Blocks Bone Erosion Associated with Inflammatory Arthritis1 , 2003, The Journal of Immunology.

[21]  D. Goeddel,et al.  The IκB Function of NF-κB2 p100 Controls Stimulated Osteoclastogenesis , 2003, The Journal of experimental medicine.

[22]  C. Scheidereit,et al.  Tetrameric Oligomerization of IκB Kinase γ (IKKγ) Is Obligatory for IKK Complex Activity and NF-κB Activation , 2003, Molecular and Cellular Biology.

[23]  S. Ghosh,et al.  Characterization of the IκB-kinase NEMO Binding Domain* , 2002, The Journal of Biological Chemistry.

[24]  G. Courtois,et al.  NEMO Trimerizes through Its Coiled-coil C-terminal Domain* , 2002, The Journal of Biological Chemistry.

[25]  A. Smahi,et al.  NEMO/IKK?: linking NF-?B to human disease , 2001 .

[26]  J. Clohisy,et al.  TAT Fusion Proteins Containing Tyrosine 42-deleted IκBα Arrest Osteoclastogenesis* , 2001, The Journal of Biological Chemistry.

[27]  S. Ghosh,et al.  Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex , 2000 .

[28]  Ulrich Siebenlist,et al.  Requirement for NF-κB in osteoclast and B-cell development , 1997 .

[29]  D. Baltimore,et al.  NF-κB Activation: The IκB Kinase Revealed? , 1997, Cell.

[30]  Matthias Mann,et al.  IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation , 1997 .

[31]  S. Teitelbaum,et al.  Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor. , 1997, The Journal of clinical investigation.

[32]  David M. Rothwarf,et al.  A cytokine-responsive IκB kinase that activates the transcription factor NF-κB , 1997, Nature.

[33]  D. Goeddel,et al.  Identification and Characterization of an IκB Kinase , 1997, Cell.

[34]  M. Omata,et al.  NEMO-Binding Domain Peptide, Blocks Inflammatory Injury in Murine Colitis , 2007 .

[35]  S. Srinivasula,et al.  Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected]. , 2006, Nature cell biology.

[36]  Toby Lawrence,et al.  IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of inflammation. , 2005, Nature.

[37]  Michael Karin,et al.  The IKK NF-κB system: a treasure trove for drug development , 2004, Nature Reviews Drug Discovery.

[38]  G. Courtois,et al.  Inhibition of NF-kappa B activation by peptides targeting NF-kappa B essential modulator (nemo) oligomerization. , 2004, The Journal of biological chemistry.

[39]  C. Scheidereit,et al.  Tetrameric oligomerization of IkappaB kinase gamma (IKKgamma) is obligatory for IKK complex activity and NF-kappaB activation. , 2003, Molecular and cellular biology.

[40]  S. Ghosh,et al.  Characterization of the Ikappa B-kinase NEMO binding domain. , 2002, The Journal of biological chemistry.

[41]  J. Pober,et al.  Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. , 2000, Science.

[42]  D B Young,et al.  IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. , 1997, Science.

[43]  A. Baldwin,et al.  THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .